Palisade Bio (PALI) Return on Equity (2016 - 2025)
Historic Return on Equity for Palisade Bio (PALI) over the last 15 years, with Q3 2025 value amounting to 3.93%.
- Palisade Bio's Return on Equity fell 21600.0% to 3.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.93%, marking a year-over-year decrease of 21600.0%. This contributed to the annual value of 1.58% for FY2024, which is 4800.0% down from last year.
- Palisade Bio's Return on Equity amounted to 3.93% in Q3 2025, which was down 21600.0% from 3.05% recorded in Q2 2025.
- In the past 5 years, Palisade Bio's Return on Equity ranged from a high of 15.8% in Q3 2021 and a low of 10.13% during Q1 2022
- For the 5-year period, Palisade Bio's Return on Equity averaged around 1.31%, with its median value being 1.41% (2024).
- Per our database at Business Quant, Palisade Bio's Return on Equity skyrocketed by 151700bps in 2021 and then plummeted by -176000bps in 2022.
- Quarter analysis of 5 years shows Palisade Bio's Return on Equity stood at 15.8% in 2021, then crashed by -108bps to 1.26% in 2022, then increased by 18bps to 1.03% in 2023, then crashed by -105bps to 2.11% in 2024, then plummeted by -86bps to 3.93% in 2025.
- Its Return on Equity stands at 3.93% for Q3 2025, versus 3.05% for Q2 2025 and 2.11% for Q1 2025.